Latent learning in End Stage Renal Disease (ESRD)

被引:5
|
作者
Jones, Daniel J. W. [1 ]
Butler, Laurie T. [1 ]
Harris, John P. [1 ]
Vaux, Emma C. [2 ]
机构
[1] Univ Reading, Sch Psychol & Clin Language Sci, Reading RG6 6AL, Berks, England
[2] Royal Berkshire NHS Fdn Trust, Dept Renal Med, Reading RG1 5AN, Berks, England
关键词
End Stage Renal Disease (ESRD); Cognitive impairment; Learning; Cortical dysfunction; CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; IRRELEVANCE; DIALYSIS; PERFORMANCE; DEPRESSION; DEMENTIA; RATES;
D O I
10.1016/j.physbeh.2015.01.033
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Cognitive functions such as attention and memory are known to be impaired in End Stage Renal Disease (ESRD), but the sites of the neural changes underlying these impairments are uncertain. Patients and controls took part in a latent learning task, which had previously shown a dissociation between patients with Parkinson's disease and those with medial temporal damage. ESRD patients (n = 24) and age and education-matched controls (n = 24) were randomly assigned to either an exposed or unexposed condition. In Phase 1 of the task, participants learned that a cue (word) on the back of a schematic head predicted that the subsequently seen face would be smiling. For the exposed (but not unexposed) condition, an additional (irrelevant) colour cue was shown during presentation. In Phase 2, a different association, between colour and facial expression, was learned. Instructions were the same for each phase: participants had to predict whether the subsequently viewed face was going to be happy or sad. No difference in error rate between the groups was found in Phase 1, suggesting that patients and controls learned at a similar rate. However, in Phase 2, a significant interaction was found between group and condition, with exposed controls performing significantly worse than unexposed (therefore demonstrating learned irrelevance). In contrast, exposed patients made a similar number of errors to unexposed in Phase 2. The pattern of results in ESRD was different from that previously found in Parkinson's disease, suggesting a different neural origin. (C) 2015 Elsevier Inc. All rights reserved.
引用
下载
收藏
页码:42 / 47
页数:6
相关论文
共 50 条
  • [21] HDL is dysfunctional in patients with end-stage renal disease (ESRD)
    Schuchardt, M.
    Toelle, M.
    Huang, T.
    Wiedon, A.
    Van Der Giet, M.
    CARDIOVASCULAR RESEARCH, 2010, 87 : S83 - S83
  • [22] Alteration of thiamine pharmacokinetics by end-stage renal disease (ESRD)
    Frank, T
    Bitsch, R
    Maiwald, J
    Stein, G
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1999, 37 (09) : 449 - 455
  • [23] Burden of end-stage renal disease (ESRD) in Latin America
    Rosa-Diez, Guillermo
    Gonzalez-Bedat, Maria
    Ferreiro, Alejandro
    Garcia-Garcia, Guillermo
    Fernandez-Cean, Juan
    Douthat, Walter
    CLINICAL NEPHROLOGY, 2016, 86 : S29 - S33
  • [24] Smoking and hyperparathyroidism in patients with end-stage renal disease (ESRD)
    Tripepi, Giovanni
    Mattace-Raso, Francesco
    Pizzini, Patrizia
    Cutrupi, Sebastiano
    Witteman, Jacqueline
    Zoccali, Carmine
    Mallamaci, Francesca
    JOURNAL OF NEPHROLOGY, 2012, 25 (01) : 75 - 83
  • [25] Foot morbidity in patients with End Stage Renal Disease (ESRD) on dialysis
    Schembri, N.
    Formosa, C.
    DIABETIC MEDICINE, 2022, 39
  • [26] COPPER AND ZINC DEPLETION IN END STAGE RENAL-DISEASE (ESRD)
    GRUPE, WE
    KOPITO, WE
    LAZARUS, JM
    BROWN, JA
    PEDIATRIC RESEARCH, 1976, 10 (04) : 439 - 439
  • [27] Symptom management in Chinese adults with end stage renal disease (ESRD)
    Levy, Nicole
    Cheung, Wing
    McDonald, Haley
    Banez, Mara Chris
    Shang, Jingjing
    Stone, Patricia W.
    Sun, Carolyn
    APPLIED NURSING RESEARCH, 2022, 64
  • [28] How end-stage renal disease (ESRD)-medicare developed
    Schreiner, GE
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (04) : S37 - S44
  • [29] End-stage renal disease (ESRD) and its treatment in Japan
    Tsukamoto, Yusuke
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (08) : 2447 - 250
  • [30] Consequences of hyperphosphatemia in patients with end-stage renal disease (ESRD)
    Qunibi, WY
    KIDNEY INTERNATIONAL, 2004, 66 : S8 - S12